Chronic Enteroviral Infection Modifies Broadly Pancreatic Cellular Functions
Lietzen et al. iScience. 19:340-357, 2019.
The goal of the new study by the research groups of Academy Professor at Turku Bioscience Centre Riitta Lahesmaa and Professor at Tampere University Heikki Hyöty was to understand the mechanisms that control the development of chronic enteroviral infection in the pancreas. The study also aimed at creating a comprehensive picture on the alterations caused by enteroviral infection that could possibly have adverse health effects.
In the study, cutting-edge proteomic methods were utilised to measure how the infection influences the expression and secretion of thousands of different proteins in the cellular models of chronic pancreatic enteroviral infection.
Having persisted for almost a year, the chronic enteroviral infections modified the cellular expression of numerous proteins that are key to cellular functions, such as proteins regulating energy metabolism. The infections also caused alterations in the secretion of several proteins.
– For example, the levels of proteins in the regulated secretory pathway participating in the secretion of hormones such as insulin in the beta-cells decreased with the chronic infection. The infections also clearly affected the levels of other proteins that are involved in the function and survival of beta-cells, says Dr Niina Lietzén from the Turku Bioscience Centre.
– Interestingly, chronic infections that had been developed by using two different virus strains triggered partly very different responses. For example, major differences in the activation of immune responses were discovered between these two models. This indicates that the viruses have different kinds of abilities to manipulate the cellular defence systems, adds Hyöty.
Published in the iScience journal, the study revealed several mechanisms through which chronic enteroviral infections can impact pancreatic functioning and possibly the development of type 1 diabetes.
The report is part of the ongoing doctoral studies of Doctoral Candidates Anni Honkimaa from Tampere University and Karoliina Hirvonen from the University of Turku.
Original publication:
Lietzén, N., Hirvonen, K., Honkimaa, A., Buchacher, T., Laiho, J.E., Oikarinen, S., Mazur, M.A., Flodström-Tullberg, M., Dufour, E., Sioofy-Khojine, A.-B., Hyöty, H., Lahesmaa, R. Coxsackievirus B persistence modifies the proteome and the secretome of pancreatic ductal cells. ISCIENCE (2019).
More information:
Riitta Lahesmaa, Academy Professor, Turku Bioscience Centre, +358 40 718 4813, rilahes@utu.fi
Heikki Hyöty, Professor, Tampere University, +358 50 516 8480, heikki.hyoty@tuni.fi
Recent Posts
-
Season’s Greetings & Happy 2026!
Season’s Greetings & Happy 2026! From everyone at Turku Bioscience. Riitta Lahesmaa,Director of Turku Bioscience Read moreDecember 23, 2025
-
The Sigrid Jusélius senior researcher posts grant to Carlos Rogerio Figueiredo
The Sigrid Jusélius Foundation has awarded a four-year senior researcher grant of €700,000 to our Read moreDecember 15, 2025
-
Guillaume Jacquemet awarded the 2025 Chancellor’s Prize
Guillaume Jacquemet, a Group Leader at our centre, has been awarded the Chancellor’s Prize for Read moreDecember 15, 2025
-
New Funding for our Centre’s Researchers
Warm congratulations to all for their funding! Cancer Foundation Finland Project grants Travel grants The Read moreDecember 12, 2025
-
Sami Ventelä and Jukka Westermarck recognized by Medical Association Duodecim for their influential work.
Medical association Duodecim selects each year persons that have been most influential in the field Read moreDecember 11, 2025
-
Our affiliated Group Leader Rafa Najumudeen secures ERC Consolidator Grant
The European Research Council (ERC) has awarded a Consolidator Grant to our affiliated Group Leader, Read moreDecember 9, 2025